SEC Filing · D
Aspargo Labs, Inc.
SEC Filing
Company context
Aspargo is a commercial stage specialty pharmaceutical and med-tech company focused on designing, developing and marketing proprietary, oral liquid suspension formulations of leading oral solid dose prescription (Rx) and over-the-counter (OTC) medications dispensed through “smart”, digitally connected, container closure drug delivery systems and associated mobile apps.
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗